AGILENT TECHNOLOGIES, INC.
AUnited States
78 filed reports · 725 financial concepts · 12 earnings calls · 1 media appearance
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Filed reports
78 reports · Jul 2016 to Jul 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 320 guidance figures, 23 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 37 | 327 | Jan 2017 to Jul 2026 |
| Quarterly · 10-QSEC EDGAR | 31 | 7,497 | Jul 2016 to Jul 2026 |
| Annual · 10-KSEC EDGAR | 10 | 7,873 | Oct 2016 to Oct 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q3 | 10-Q | 2026-07-31 | 2026-09-01 | 456 | Open |
| FY2026 Q3 | 8-K | 2026-07-31 | 2026-08-26 | 17 | Open |
| FY2026 Q2 | 10-Q | 2026-04-30 | 2026-06-01 | 339 | Open |
| FY2026 Q2 | 8-K | 2026-04-30 | 2026-05-27 | 10 | Open |
| FY2026 Q1 | 10-Q | 2026-01-31 | 2026-03-03 | 330 | Open |
| FY2026 Q1 | 8-K | 2026-01-31 | 2026-02-25 | 12 | Open |
| FY2025 | 10-K | 2025-10-31 | 2025-12-22 | 1,350 | Open |
| FY2025 Q4 | 8-K | 2025-10-31 | 2025-11-24 | 8 | Open |
| FY2025 Q3 | 10-Q | 2025-07-31 | 2025-08-29 | 230 | Open |
| FY2025 Q3 | 8-K | 2025-07-31 | 2025-08-27 | 8 | Open |
| FY2025 Q2 | 10-Q | 2025-04-30 | 2025-06-02 | 212 | Open |
| FY2025 Q2 | 8-K | 2025-04-30 | 2025-05-28 | 8 | Open |
Financial data
725 concepts · 15,697 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial685 concepts · 13,148 facts · Oct 2014 to Jul 2026
- Standard product warranty accrual58 · Oct 2014 to Jul 2026
- Accumulated other comprehensive income loss net of tax57 · Oct 2014 to Jul 2026
- Allocated share based compensation expense57 · Oct 2014 to Jul 2026
- Amortization of intangible assets57 · Oct 2014 to Jul 2026
- Cash and cash equivalents at carrying value57 · Jul 2015 to Jul 2026
- Costs and expenses57 · Oct 2014 to Jul 2026
- Impairment of intangible assets indefinitelived excluding goodwill57 · Oct 2014 to Jul 2026
- Income tax expense benefit57 · Oct 2014 to Jul 2026
- Interest expense (US GAAP)57 · Oct 2014 to Jul 2026
- Investment income interest57 · Oct 2014 to Jul 2026
- Operating income loss57 · Oct 2014 to Jul 2026
- Other comprehensive income defined benefit plans net unamortized gain loss arising during period net of tax57 · Oct 2014 to Jul 2026
- Other comprehensive income defined benefit plans net unamortized gain loss arising during period tax57 · Oct 2014 to Jul 2026
- Other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax57 · Oct 2014 to Jul 2026
- Other comprehensive income loss foreign currency translation adjustment tax57 · Oct 2014 to Jul 2026
- Other comprehensive income loss net of tax57 · Oct 2014 to Jul 2026
- Other nonoperating income expense57 · Oct 2014 to Jul 2026
- Payments of dividends common stock57 · Oct 2014 to Jul 2026
- Research and development expense57 · Oct 2014 to Jul 2026
- Revenue57 · Oct 2014 to Jul 2026
- Selling general and administrative expense57 · Oct 2014 to Jul 2026
- Deferred income tax expense benefit56 · Oct 2014 to Jul 2026
- Depreciation depletion and amortization56 · Oct 2014 to Jul 2026
- Goodwill impairment loss56 · Oct 2014 to Jul 2026
Segment26 concepts · 1,749 facts · Oct 2014 to Jul 2026
- Revenue598 · Oct 2014 to Jul 2026
- Operating income loss225 · Oct 2014 to Jul 2026
- Total Assets161 · Oct 2015 to Jul 2025
- Goodwill155 · Oct 2015 to Apr 2026
- Goodwill acquired during period93 · Oct 2015 to Oct 2025
- Goodwill translation and purchase accounting adjustments90 · Jan 2017 to Jul 2026
- Depreciation70 · Oct 2014 to Jul 2026
- Allocated share based compensation expense40 · Oct 2021 to Jul 2026
- Share based compensation36 · Oct 2014 to Oct 2022
- Goodwill foreign currency translation gain loss35 · Oct 2015 to Oct 2025
- Operating Income32 · Jul 2015 to Jul 2023
- Payments to acquire property plant and equipment32 · Oct 2015 to Oct 2022
- Cost of goods and services sold (US GAAP)30 · Oct 2023 to Jul 2026
- Research and development expense30 · Oct 2023 to Jul 2026
- Selling general and administrative expense30 · Oct 2023 to Jul 2026
- Revenue (excluding assessed tax)24 · Jul 2017 to Apr 2023
- Goodwill transfers21 · Oct 2018 to Jan 2025
- Revenue from contracts with customers (excluding tax)12 · Oct 2016 to Apr 2018
- Segment expenditure addition to long lived assets9 · Oct 2022 to Oct 2024
- Capital Expenditures8 · Oct 2015 to Oct 2022
- Goodwill purchase accounting adjustments5 · Jan 2025 to Oct 2025
- Stock-Based Compensation5 · Oct 2015 to Oct 2022
- Goodwill written off related to sale of business unit3 · Oct 2023
- Indefinite lived intangible assets purchase accounting adjustments3 · Jul 2019 to Oct 2019
Guidance8 concepts · 327 facts · Feb 2017 to Aug 2026
- Revenue Guidance146 · Feb 2017 to Aug 2026
- EPS (Diluted) Guidance142 · Feb 2017 to May 2026
- Revenue Growth Guidance26 · Feb 2017 to Aug 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))4 · Aug 2026
- Revenue Growth Guidance (Adjusted (non-GAAP))4 · Aug 2026
- Free Cash Flow Guidance2 · Aug 2017
- Operating Margin Guidance2 · May 2026
- Operating Margin Guidance (Adjusted (non-GAAP))1 · Aug 2026
Product4 concepts · 311 facts · Oct 2014 to Jul 2026
- Revenue205 · Oct 2014 to Jul 2026
- Cost of goods and services sold (US GAAP)90 · Oct 2016 to Jul 2026
- Prior period reclassification adjustment12 · Oct 2016 to Oct 2017
- Cost of revenue (US GAAP)4 · Jul 2017 to Jul 2018
Geography2 concepts · 162 facts · Oct 2014 to Jul 2026
- Revenue156 · Oct 2014 to Jul 2026
- Cash and Equivalents6 · Oct 2020 to Oct 2025
Segments
2,222 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments16 members · 1,749 facts
- Agilent Cross Lab386 · Oct 2014 to Jul 2026
- Life Sciencesand Applied Markets302 · Oct 2014 to Oct 2024
- Diagnostics And Genomics294 · Oct 2014 to Oct 2024
- Applied Markets135 · Oct 2023 to Jul 2026
- Life Sciences And Diagnostics Markets135 · Oct 2023 to Jul 2026
- Segment Total109 · Oct 2014 to Jul 2023
- Agilent cross lab98 · Oct 2015 to Apr 2026
- Segment total90 · Jul 2015 to Jul 2023
- Diagnostics and genomics86 · Oct 2015 to Oct 2024
- Life sciencesand applied markets83 · Oct 2015 to Oct 2024
- Applied markets13 · Oct 2024 to Apr 2026
- Life sciences and diagnostics markets13 · Oct 2024 to Apr 2026
- Corporate and other2 · Oct 2022 to Jul 2023
- Assetimpairment1 · Oct 2014
- Diagnosticsandgenomicssolutions1 · Oct 2018
- NMR1 · Oct 2014
Product or servicesrt:ProductOrServiceAxis10 members · 287 facts
- Product94 · Oct 2016 to Jul 2026
- Service Other94 · Oct 2016 to Jul 2026
- Instrumentation41 · Oct 2016 to Jul 2026
- Non Instrumentationand Other38 · Jan 2019 to Jul 2026
- Servicesandothercostofsales4 · Oct 2016 to Oct 2017
- Servicesandotherrevenue4 · Oct 2016 to Oct 2017
- Analyticallabconsumables3 · Oct 2016 to Oct 2018
- Analytical Lab Services3 · Oct 2016 to Oct 2018
- Diagnosticsandgenomicssolutions3 · Oct 2016 to Oct 2018
- Informaticsandother3 · Oct 2016 to Oct 2018
Statement geographicalsrt:StatementGeographicalAxis7 members · 150 facts
- Americas38 · Jan 2019 to Jul 2026
- Asia Pacific38 · Jan 2019 to Jul 2026
- Europe38 · Jan 2019 to Jul 2026
- CN10 · Oct 2016 to Oct 2025
- Rest Of World10 · Oct 2016 to Oct 2025
- US10 · Oct 2016 to Oct 2025
- Non us6 · Oct 2020 to Oct 2025
Product or serviceus-gaap:ProductOrServiceAxis7 members · 24 facts
- Analyticallabconsumables4 · Oct 2014 to Oct 2017
- Analytical Lab Services4 · Oct 2014 to Oct 2017
- Diagnosticsandgenomicssolutions4 · Oct 2014 to Oct 2017
- Informaticsandother4 · Oct 2014 to Oct 2017
- Instrumentation4 · Oct 2014 to Oct 2017
- Servicesandothercostofsales2 · Jan 2017 to Apr 2017
- Servicesandotherrevenue2 · Jan 2017 to Apr 2017
Statement geographicalus-gaap:StatementGeographicalAxis3 members · 12 facts
- CN4 · Oct 2014 to Oct 2017
- Rest Of World4 · Oct 2014 to Oct 2017
- US4 · Oct 2014 to Oct 2017
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary24 claims from 8 reports · Oct 2024 to Jul 2026
- Management discussion (MD&A) commentary185 claims from 8 reports · Oct 2024 to Jul 2026
- Risk-factor changes42 claims from 9 reports · Oct 2017 to Oct 2025
- Risk factors331 risks from 10 annual reports · 2016 to 2025
Earnings calls
12 calls · Nov 2023 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q32026-08-26
- FY2026 Q22026-05-27
- FY2026 Q12026-02-25
- FY2025 Q42025-11-24
- FY2025 Q32025-08-27
- FY2025 Q22025-05-28
- FY2025 Q12025-02-26
- FY2024 Q42024-11-25
- FY2024 Q32024-08-21
- FY2024 Q22024-05-29
- FY2024 Q12024-02-27
- FY2023 Q42023-11-20
Executive media
1 appearancePodcasts, interviews and conference appearances by the company's executives, with their claims.
- TV interviews1 · Dec 2024
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of AGILENT TECHNOLOGIES, INC. (A) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.